|
Originally published In Press as doi:10.1074/jbc.M605273200 on June 27, 2006
J. Biol. Chem., Vol. 281, Issue 35, 25447-25456, September 1, 2006
Rheb Inhibits C-Raf Activity and B-Raf/C-Raf Heterodimerization*
Magdalena Karbowniczek ,
Gavin P. Robertson , and
Elizabeth Petri Henske 1
From the
Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 and the Pharmacology Department, Pennsylvania State College of Medicine, Hershey, Pennsylvania 17033
The Ras-Raf-MEK signaling cascade is critical for normal development and is activated in many forms of cancer. We have recently shown that B-Raf kinase interacts with and is inhibited by Rheb, the target of the GTPase-activating domain of the tuberous sclerosis complex 2 gene product tuberin. Here, we demonstrate for the first time that activation of Rheb is associated with decreased B-Raf and C-Raf phosphorylation at residues Ser-446 and Ser-338, respectively, concomitant with a decrease in the activities of both kinases and decreased heterodimerization of B-Raf and C-Raf. Importantly, the impact of Rheb on B-Raf/C-Raf heterodimerization and kinase activity are rapamycin-insensitive, indicating that they are independent of Rheb activation of the mammalian target of rapamycin-Raptor complex. In addition, we found that Rheb inhibits the association of B-Raf with H-Ras. Taken together, these results support a central role of Rheb in the regulation of the Ras/B-Raf/C-Raf/MEK signaling network.
Received for publication, June 1, 2006
, and in revised form, June 23, 2006.
* This work was supported by National Institutes of Health Grant DK 51052, The LAM Foundation (Cincinnati, OH), and The Rothberg Foundation for Childhood Diseases (Guilford, CT). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, PA 19111. Tel.: 215-728-2428; Fax: 215-214-1623; E-mail: Elizabeth.Henske{at}fccc.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Koh, K. Sachidanandam, A. N. Stratman, A. Sacharidou, A. M. Mayo, E. A. Murphy, D. A. Cheresh, and G. E. Davis
Formation of endothelial lumens requires a coordinated PKC{epsilon}-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation
J. Cell Sci.,
June 1, 2009;
122(11):
1812 - 1822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hamada, K. Hara, T. Hamada, H. Yasuda, H. Moriyama, R. Nakayama, M. Nagata, and K. Yokono
Upregulation of the Mammalian Target of Rapamycin Complex 1 Pathway by Ras Homolog Enriched in Brain in Pancreatic {beta}-Cells Leads to Increased {beta}-Cell Mass and Prevention of Hyperglycemia
Diabetes,
June 1, 2009;
58(6):
1321 - 1332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Yu, V. A. Robb, T. A. Morrison, E. A. Ariazi, M. Karbowniczek, A. Astrinidis, C. Wang, L. Hernandez-Cuebas, L. F. Seeholzer, E. Nicolas, et al.
Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells
PNAS,
February 24, 2009;
106(8):
2635 - 2640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Feng, R. E. Brown, C. D. Trung, W. Li, L. Wang, T. Khoury, S. Alrawi, J. Yao, K. Xia, and D. Tan
Morphoproteomic Profile of mTOR, Ras/Raf Kinase/ERK, and NF-{kappa}B Pathways in Human Gastric Adenocarcinoma
Ann. Clin. Lab. Sci.,
January 1, 2008;
38(3):
195 - 209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Habib, D. J. Riley, L. Mahimainathan, B. Bhandari, G. G. Choudhury, and H. E. Abboud
Tuberin regulates the DNA repair enzyme OGG1
Am J Physiol Renal Physiol,
January 1, 2008;
294(1):
F281 - F290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Malagelada, E. J. Ryu, S. C. Biswas, V. Jackson-Lewis, and L. A. Greene
RTP801 Is Elevated in Parkinson Brain Substantia Nigral Neurons and Mediates Death in Cellular Models of Parkinson's Disease by a Mechanism Involving Mammalian Target of Rapamycin Inactivation
J. Neurosci.,
September 27, 2006;
26(39):
9996 - 10005.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|